Ticker Details
Lantheus Holdings, Inc. Lantheus Holdings Inc develops diagnostic products for the healthcare sector. Its chief product is imaging agents used by physicians in diagnostic procedures such as cardiac ultrasounds and X-ray imaging.
IPO Date:	June 25, 2015
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$6.9B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.92 | 2.50%
Avg Daily Range (30 D):	$1.61 | 1.56%
Avg Daily Range (90 D):	$1.68 | 1.92%

Institutional Daily Volume
Avg Daily Volume:	.59M
Avg Daily Volume (30 D):	.77M
Avg Daily Volume (90 D):	.78M

Trade Size
Avg Trade Size (Sh.):	64
Avg Trade Size (Sh.) (30 D):	53
Avg Trade Size (Sh.) (90 D):	51

Institutional Trades
Total Institutional Trades:	6,202
Avg Institutional Trade:	$3.59M
Avg Institutional Trade (30 D):	$7.72M
Avg Institutional Trade (90 D):	$6.31M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$6.25M
Avg Closing Trade (30 D):	$19.33M
Avg Closing Trade (90 D):	$14.51M
Avg Closing Volume:	108.51K

News

Jun 10, 2026 @ 5:00 PM Metastatic Prostate Cancer Market Set for Robust G... Source: Delveinsight

Apr 24, 2026 @ 1:57 PM Radiopharmaceuticals Market Size to Exceed USD 15.... Source: Precedence Research

Feb 26, 2026 @ 12:00 PM Lantheus Reports Fourth Quarter and Full Year 2025... Source: Na

Feb 20, 2026 @ 3:55 PM PSMA-Targeted Therapy & Radiodiagnostics Competito... Source: Researchandmarkets.Com

Feb 12, 2026 @ 1:00 PM Lantheus to Host Fourth Quarter and Full Year 2025... Source: Na

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$4.22	$1.83	$.83
Diluted EPS	$4.14	$1.8	$.81
Revenue	$1.55B	$377.33M	$406.79M
Gross Profit	$935.17M	$230.92M	$240.88M
Net Income / Loss	$279.03M	$118.42M	$54.09M
Operating Income / Loss	$290.09M	$81.33M	$77.18M
Cost of Revenue	$611M	$146.41M	$165.91M
Net Cash Flow	$-439.92M	$139.47M	$-22.88M
PE Ratio